Qile Song

Qile Song

Auto-generated profile, based on publicly available information

Qile Song


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2023 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
LFLina Feng
Lina Feng
GWGuojun Wang
Guojun Wang
QSQile Song
Qile Song
FXFeng Xiaotong
Feng Xiaotong
JSJing Su
Jing Su
MLMingquan Li
Mingquan Li

1 April 2026 in Bioactive Materials
Verified
Journal Article
Open access
ZWZekun Wang
Zekun Wang
RZRuofei Zhang
Ruofei Zhang
YHYanyu Hu
Yanyu Hu
QSQile Song
Qile Song
XFXiaoyan Fu
Xiaoyan Fu
DSDongdong Sun
Dongdong Sun
Doxorubicin (DOX) treatment can lead to intracellular iron overload in cardiomyocytes, triggering excessive generation of reactive oxygen species (ROS) and resulting in cardiotoxicity. Superoxide dismutase (SOD) effectively scavenges ROS, and its catalytic activity depends on the binding of metal ions at its active site. Therefore, enhancing the activity of metal-dependent SOD represents a promising strategy to inhibit ferroptosis in cardiomyocytes and alleviate DOX-induced chronic heart failure. In this study, we constructed a biomimetic chiral MnO2 nanozyme co-modified with macrophage and platelet membranes (D/L-MnO2@MM), enabling precise targeting of DOX-injured myocardial tissues. This nanozyme exhibited potent catalase-like and SOD-like activities, efficiently eliminating excessive local hydrogen peroxide (H2O2) and superoxide anions (O2•−). Notably, the D-enantiomeric nanozyme (D-MnO2@MM) significantly enhanced endogenous SOD2 activity via Mn2+ ion release, thereby suppressing the accumulation of lipid peroxides. Furthermore, based on transcriptomic and proteomic analyses, we designed an siRNA targeting the Hmox1 gene (siHmox1) and successfully loaded it onto the nanozyme platform (siHmox1@D/L-MnO2@MM). Both in vitro and in vivo experiments confirmed that the dual mechanism, SOD2 activation and Hmox1 silencing, effectively restored mitochondrial function, attenuated ferroptosis, and significantly improved cardiac function in a rat model of chronic heart failure. Collectively, this study proposes a novel ferroptosis-targeted therapeutic strategy based on a biomimetic chiral nanozyme, offering new insights and promising therapeutic potential for the treatment of DOX-induced cardiotoxicity.

9 February 2024 in Journal of Food Biochemistry
Verified
Journal Article
Open access
PDF file
YYYong Yang
Yong Yang
HYHong Yang
Hong Yang
FXFeng Xiaotong
Feng Xiaotong
QSQile Song
Qile Song
JCJie Cui
Jie Cui
YPYechun Pei
Yechun Pei
Osteoporosis (OP) is a systemic bone disease with loss of bone mass and destruction of the microscopic structure. Many antiosteoporosis drugs have been used for OP therapy, but the therapeutic efficiency remains limited. Therefore, there is an urgent need to develop new drugs for antiosteoporosis treatment. Selenium (Se) is one kind of essential trace element for humans and displays pivotal roles in maintaining bone homeostasis. However, the modulation roles of Se are greatly affected by its chemical forms. Herein, Se containing protein derived from Se-enriched Spirulina platensis (Se-SP) were extracted and used for the treatment of OP in an ovariectomized mice model. The results showed that Se-SP showed enhanced potential in promoting excretion of calcium and alkaline phosphatase (ALP) expression than that of SP in MC3T3-E1 cells. Micro-CT revealed that Se-SP administration in vivo effectively alleviated bone loss as indicated by the upregulated BV, Tb.Th, Bv/TV, Tb.N, and BMD as well as the decreased Tb.Sp. Se-SP in vivo also significantly suppressed inflammatory response through restricting the expression of proinflammatory cytokines expression and upregulating the secretion of anti-inflammatory cytokines. Additionally, Se-SP effectively inhibited ovariectomy-induced osteoblast inactivation and osteoclastogenesis by upregulating BMP2, RUNX2, COL-I, OCN and OPG pression and downregulating RANKL expression. Together, these findings suggested that Se-SP was a new form of Se in therapy of human OP.

18 August 2025 in Biomaterials
Verified
Journal Article
Open access
CDChunxue Dai
Chunxue Dai
YHYingjiao He
Yingjiao He
HLHongyan Lu
Hongyan Lu
XFXiaotong Feng
Xiaotong Feng
NLNaling Long
Naling Long
DSDongdong Sun
Dongdong Sun
Hydrogen therapy as an emerging strategy for anticancer medicine is attracting attention. However, the limitations of effective hydrogen storage and release have hindered its development and application for hydrogen therapy. Herein, a high hydrogen storage nanoquadruplex (PdH0.2)4Se based on a palladium-selenium core has been designed and shows enhanced intratumoral accumulation via an enhanced permeability and retention (EPR) effect. High-efficiency hydrogen can be released from (PdH0.2)4Se, activated by near infrared irradiation (NIR), and combines with available selenium (Se) to produce highly toxic hydrogen selenide (H2Se), which in turn unbalances the GSH/GSSG ratio and induces ROS overproduction. The effect demonstrates that (PdH0.2)4Se irradiated by NIR significantly inhibits cancer cell proliferation, migration, invasion and angiogenesis in vitro. Furthermore, irradiation of (PdH0.2)4Se by NIR can induce significant ferroptosis of cancer cells by triggering mitochondrial dysfunction, ROS generation and lipid peroxidation-mediated oxidative damage in vitro. Finally, NIR irradiated (PdH0.2)4Se also exhibits tumor-targeted photothermal imaging, and inhibition of tumor growth in vivo activating cancer ferroptosis. Importantly, (PdH0.2)4Se demonstrates excellent safety and biocompatibility in vitro and in vivo. Thus together, our findings support the rational design of an effective hydrogen storage (PdH0.2)4Se nanoquadruplex with NIR-controlled release causing an unbalance of cellular GSH/GSSG and inducing cancer ferroptosis could be a highly efficient strategy for hydrogen-mediated cancer therapy.

17 June 2025 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
HYHuiying Yan
Huiying Yan
LFLimei Fang
Limei Fang
CQChang Qi
Chang Qi
MLMingquan Li
Mingquan Li
QSQile Song
Qile Song
LFLina Feng
Lina Feng
Objectives: Investigate Naochuxue formula’s mechanism in the treatment of subarachnoid hemorrhage. Methods: Analyzed Naochuxue formula’s active components via nontargeted metabolomics, and predicted the core targets using network pharmacology. Sprague‒Dawley rats were randomly divided into six groups: sham, model, Naochuxue formula low, medium and high dose groups, and edaravone. Neurological deficits were assessed using the modified Garcia score and tissue damage was assessed by measuring the brain water content. Blood‒brain barrier permeability was assessed using the Evans blue procedure and pathological changes in the lesion site were observed through HE staining and Nissl staining. TUNEL staining and Caspase-3 immunofluorescence were used to observe the apoptosis of neurons in the hippocampus. The distribution and expression of p-PI3K and p-AKT were determined using immunohistochemistry. The expression of the apoptosis-related genes Caspase-3, Bcl-2, and Bax was determined using RT‒PCR. Key findings: Compared with the model group, rats in the high-dose Naochuxue formula group exhibited significant improvements in neurological defects, brain histopathology, blood‒brain barrier permeability and brain edema on Day 3 posttreatment, downregulated Bax and Caspase-3 expression, and significantly upregulated p-PI3K, p-AKT, and Bcl-2 expression (all P < 0.05). Conclusions: High-dose formula for 3 days activated PI3K/AKT signaling pathway, inhibitd neuronal apoptosis, and exerted neuroprotective effects.

28 February 2024 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
WCWang Chen
Wang Chen
PHPida Hao
Pida Hao
QSQile Song
Qile Song
FXFeng Xiaotong
Feng Xiaotong
XZXuan Zhao
Xuan Zhao
XWXianjun Wang
Xianjun Wang